Fred J. Ansfield

Fred Joseph Ansfield, M.D. (1910 - 1996) was an American pioneer of medical oncology. He was a leader in applying 5-FU (5-Fluorouracil) to humans, demonstrating its effectiveness as a chemotherapy drug.[1][2] Ansfield co-founded the American Society of Clinical Oncology (ASCO) in 1964, along with Harry Bisel, Arnoldus Goudsmit, Herman H. Freckman, Robert W. Talley, William Wilson and Jane Cooke Wright.[3]  He served as ASCO's third president (1966–1967).[4]

Dr. Fred J Ansfield

"He shall be remembered by cancer treatment specialists everywhere as one of the founders of Medical Oncology."[1]

  1. ^ a b Mehta, Minesh P.; Paliwal, Bhudatt R.; Clifton, Kelly H. "MEMORIAL RESOLUTION OF THE FACULTY OF THE UNIVERSITY OF WISCONSIN-MADISON ON THE DEATH OF PROFESSOR EMERITUS FRED JOSEPH ANSFIELD". University of Wisconsin Knowledgebase. University of Wisconsin. Retrieved 14 March 2019.
  2. ^ ANSFIELD, FJ; SCHROEDER, JM; CURRERI, AR (July 28, 1962). "Five Years Clinical Experience with 5-Fluorouracil". JAMA. 181 (4): 181, 295–9. doi:10.1001/jama.1962.03050300015003. PMID 13861733. Retrieved 14 March 2019.
  3. ^ "Founders". ASCO. Retrieved 14 March 2019.
  4. ^ "Past Presidents". ASCO. Retrieved 13 March 2019.